Glimepiride
56 NDCs across 11 manufacturers|56 Generic,0 Brand
Glimepiride is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 30, 1995, and the first generic was approved Oct 6, 2005. FDA's Orange Book lists 26 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $41 million on Glimepiride across 4.6 million claims for 1.2 million beneficiaries.
Glimepiride is available as 56 NDCs from 11 manufacturers (56 generic, 0 brand), with NADAC prices from $0.02 to $0.12 per EA — the most expensive product costs about 5.5× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
56
56G / 0B
Manufacturers
11
competing in market
Price Spread
$0.02 – $0.12
per EA
7d Activity
avg +0.3% WoW · of 56 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Micro Labs Limited manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Sulfonylurea class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
11 manufacturers producing GLIMEPIRIDE(3 pricing outliers)
Frequently Asked Questions
What is Glimepiride used to treat?
Glimepiride is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
When did Glimepiride become available as a generic?
FDA approved the first generic Glimepiride (ANDA) on Oct 6, 2005. The Orange Book currently lists 26 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Glimepiride?
In 2024, Medicare Part D spent $41 million on Glimepiride across 4.6 million claims for 1.2 million beneficiaries.
How many Glimepiride products are on the market?
The Glimepiride drug market contains 56 NDCs from 11 manufacturers — 56 generic and 0 brand products.
What is the price range for Glimepiride?
NADAC reference prices for Glimepiride range from $0.0222 to $0.1223 per EA — the most expensive product costs about 5.5× the cheapest.
Which manufacturers make Glimepiride?
11 manufacturers list Glimepiride in NADAC. Ranked by number of NDCs, the largest are Micro Labs Limited (6), Accord Healthcare Inc. (6), Dr. Reddy's Laboratories Inc. (6), BluePoint Laboratories (6), Carlsbad Technology Inc. (6).
How has the price of Glimepiride changed recently?
Over the past 7 days, 31 Glimepiride NDCs rose and 17 fell, with a market-wide average change of +0.3%.